A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX
Phase of Trial: Phase IV
Latest Information Update: 19 Sep 2016
At a glance
- Drugs Folitixorin (Primary) ; Methotrexate
- Indications Folic acid deficiency; Osteosarcoma
- Focus Therapeutic Use
- Acronyms FORTO
- Sponsors Isofol Medical
- 02 Sep 2016 Status changed from recruiting to completed.
- 24 Aug 2015 Planned End Date changed from 1 May 2015 to 1 Nov 2015, as reported by ClinicalTrials.gov.
- 24 Aug 2015 Planned primary completion date changed from 1 May 2015 to 1 Nov 2015, as reported by ClinicalTrials.gov.